NASDAQ NMS - GLOBAL MARKET · ENLV
+0.67% · +$0.0100 · Vol 157.5K
Market closed · last close 4:00 PM ET · price as of 19:46:18 ET
Enlivex Ltd

Enlivex Ltd

Biotechnology
$1.51
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Valuation absence reason unknown · Earnings absence reason unknown
ENLV
Enlivex Ltd
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

37/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ENLV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ENLV catalysts
About Enlivex Ltd
Biotechnology
Listed since
2014
Employees
34
Country
IL

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.49
Day high
$1.52
Day low
$1.39
Previous close
$1.50
52W high
$18.15
-91.68% from high
52W low
$1.39
1% of range
Market cap
$25.7M
P/E
0.02×
EPS
$149.75
Beta
1.02
Shares out
17.5M
Volume
157.5K
0.45× rel vol
Avg volume
349.9K
VWAP
$1.47
Price history computed in-house
1W
-4.43%
1M
-64.05%
3M
-85.97%
1Y
-90.41%
YTD
-85.68%
SMA 50 $5.28 · below
SMA 200 $11.94 · below
52W position 1%

ENLV overview

Veridion Score
37
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ENLV.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ENLV Form 4 filings
Public disclosures

Congress activity in ENLV

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ENLV in the cached public ledger.

Federal contracts

ENLV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ENLV in this window.
Lobbying spend

ENLV lobbying filings, year to date.

Registered lobbying filings matched to Enlivex Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ENLV in this window.
Loading news for ENLV
Analyst ratings
Sovereign unlock shows live analyst consensus for ENLV.
Options
Sovereign unlock shows live options positioning for ENLV.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.